Immunohistochemistry Market
Number of pages: 100 | Report Format: PDF | Published date: June 30, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 3.10 billion |
|
Revenue Forecast in 2031 |
US$ 5.87 billion |
|
CAGR |
7.35% |
|
Base Year For Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product, Application, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global Immunohistochemistry Market was valued at US$ 3.10 billion in 2022 and is expected to register a revenue CAGR of 7.35% to reach US$ 5.87 billion by 2031.
Immunohistochemistry Market Fundamentals
Immunohistochemistry (IHC) is a widely used laboratory technique that combines immunological methods with histological analysis to visualize specific proteins or antigens in tissue samples. It provides valuable information about target molecules' distribution, localization, and expression levels within cells and tissues. Immunohistochemistry has applications in various fields, including medical research, diagnostics, and pathology. The technique is based on using specific antibodies that recognize and bind to the target antigens in the tissue sections. These antibodies are typically generated in the laboratory by immunizing animals with purified proteins or synthetic peptides corresponding to the target antigen. Once produced, the antibodies can selectively bind to the specific antigen in the tissue sample.
In recent years, immunohistochemistry has witnessed several significant trends. These trends signify technological progress, the broadening of research areas, and the evolution of methodologies. Multiplex immunohistochemistry allows the simultaneous detection of multiple targets within a single tissue section. This technique has gained significant attention, enabling researchers to study complex interactions between different cell types and proteins within the tissue microenvironment. Additionally, spatial profiling techniques, such as spatial transcriptomics, combine molecular information with spatial context, providing a deeper understanding of cellular organization and function.
Immunohistochemistry Market Dynamics
The rising incidence of cancer and chronic diseases significantly drives the immunohistochemistry market. Immunohistochemistry plays a crucial role in diagnosing, classifying, and prognosis of various cancers, including breast, lung, prostate, and colorectal. The National Centres for Biotechnology Information (NCBI) predicts that in 2022, China and the USA will see around 4,820,000 and 2,370,000 new cancer cases, respectively, with approximately 3,210,000 and 640,000 cancer-related deaths in each country. As the global burden of cancer increases, the demand for accurate and reliable diagnostic techniques, such as IHC (Immunohistochemistry), is growing. Additionally, immunohistochemistry is used in the study of other chronic diseases, such as autoimmune disorders and neurological disorders, contributing to its market growth.
Personalized medicine and targeted therapies are gaining prominence in healthcare. Immunohistochemistry is critical in identifying predictive biomarkers and therapeutic targets, aiding treatment decisions and patient stratification. The immunohistochemistry technique enables physicians to evaluate protein expression patterns in patient samples, aiding them in determining suitable treatment options and tracking treatment progress. As personalized medicine becomes more prevalent in clinical practice, the demand for IHC-based companion diagnostic tests and biomarker analysis is projected to increase.
Technological advancements in immunohistochemistry, such as automated platforms, digital imaging, and image analysis software, have streamlined workflows, improved efficiency, and enhanced the accuracy and reproducibility of results. Automation reduces manual labor, minimizes human error, and enables high-throughput analysis, making immunohistochemistry more accessible and cost-effective. These advancements have fueled the adoption of immunohistochemistry in research laboratories, clinical settings, and diagnostic laboratories, driving market growth.
While several factors drive the growth of the immunohistochemistry (IHC) market, certain restraining factors can affect its adoption and market expansion. Immunohistochemistry can be a relatively expensive and technically demanding technique. The cost of acquiring high-quality antibodies, reagents, and specialized equipment can establish a financial burden, especially for small research laboratories or healthcare facilities with limited resources.
Market Ecosystem
The global immunohistochemistry market is analyzed from the following perspectives: product, application, and end user.
Immunohistochemistry Market by Product
Based on the products, the global immunohistochemistry market is segmented into reagents, antibodies, and equipment.
The antibodies segment accounted for 39% of the global immunohistochemistry market share in 2022. The segment is segmented into primary antibodies and secondary antibodies. The growth of the antibody segment is attributed to the growing demand for personalized medicine and targeted therapies, which require accurate and precise identification of specific biomarkers. The increasing prevalence of chronic diseases such as cancer and autoimmune disorders has also contributed to the growth of the antibodies segment. Moreover, due to technological advancements and the emergence of new antibodies, this particular segment is predicted to maintain its leading position in the immunohistochemistry market for the foreseeable future.
Immunohistochemistry Market by Application
Based on the applications, the global immunohistochemistry market is segmented into diagnostic applications, research and development, and forensic applications.
The diagnostic application segment accounted for 68.12% of the global immunohistochemistry market in 2022. The diagnostics segment is again classified into nephrological diseases, infectious diseases, diabetes mellitus, cardiovascular diseases, cancer, and autoimmune diseases. Among these, the cancer sub-segment has dominated the market with the largest share during the forecast period. This can be attributed to the rising prevalence of cancer globally and the increasing demand for accurate and effective diagnostic tools for cancer detection and treatment. Furthermore, the growing awareness regarding early cancer detection and the availability of advanced immunohistochemistry-based diagnostic tests are also contributing to the growth of this sub-segment.
Immunohistochemistry Market by End User
Based on the end users, the global immunohistochemistry market is segmented into academic & research institutes, hospitals & diagnostic laboratories, and others.
The hospitals & diagnostic laboratories segment dominated the global immunohistochemistry market. This can be attributed to the increasing prevalence of chronic diseases and the growing demand for personalized medicine. The rising incidence of cancer and autoimmune disorders has increased the demand for immunohistochemistry tests, as they help diagnose and treat these diseases. Moreover, the development of advanced technologies and the availability of automated instruments have made immunohistochemistry testing more efficient and accurate, thereby contributing to the growth of this market. Additionally, the increasing focus on research and development activities and the rising investments in the healthcare sector is expected to drive the growth of the immunohistochemistry market in the coming years.
Immunohistochemistry Market by Region
Based on the region, the immunohistochemistry market is segmented into North America, Europe, Asia Pacific, Latin America, & the Middle East & Africa.
North America accounted for 37.62% of the global immunohistochemistry market share 2022. The dominance of North America can be attributed to the growing prevalence of chronic diseases, such as cancer and cardiovascular diseases, and the increasing demand for personalized medicine. In the United States alone, around 1.8 million new cancer cases were diagnosed in 2021, as reported by the American Cancer Society. Cardiovascular diseases are the country's number one cause of death, resulting in roughly 655,000 deaths yearly. A Grand View Research report projects that the North American personalized medicine market will grow to $2.4 billion by 2022. Additionally, established healthcare infrastructure and favorable reimbursement policies are expected drive the growth of the immunohistochemistry market in North America. The United States, in particular, is anticipated to witness significant growth owing to the rising adoption of advanced diagnostic technologies and the increasing focus on precision medicine.
The Asia Pacific immunohistochemistry market is expected to register 7.95% revenue CAGR in the forecast years. This growth is attributed to the increasing prevalence of chronic diseases and the rising demand for personalized medicine. In regions like Japan, the increasing investments by governments and private organizations in research and development activities are expected to fuel the market growth in Asia Pacific. The growing adoption of advanced technologies such as genomics and proteomics is also expected to drive market revenue growth. In addition, the increasing investment in healthcare infrastructure and the growing awareness about the benefits of immunohistochemistry are driving market growth in the region.
Immunohistochemistry Market Strategic Developments
Immunohistochemistry Market Competitive Landscape
The competitive landscape for the immunohistochemistry market is highly fragmented, with several established players and new entrants vying for market share. These companies have a strong presence in the market owing to their wide range of products and services, extensive distribution networks, and strategic partnerships and collaborations.
Some of the prominent companies having the largest revenue share in the global immunohistochemistry market are,
Immunohistochemistry (IHC) is a widely used laboratory technique that combines immunological methods with histological analysis to visualize specific proteins or antigens in tissue samples.
The global immunohistochemistry market has witnessed significant growth over the years, owing to the increasing prevalence of chronic diseases and technological advancements.
The global immunohistochemistry market is expected to register a revenue CAGR of 7.35% in the forecast period from 2022 to 2031.
North America accounted for the majority of the global immunohistochemistry market, with the majority of the market revenue share in 2022. This is due to the presence of a high patient pool and the presence of many top market players in the region.
The global immunohistochemistry market was valued at US$ 3.10 billion in 2022.
*Insights on financial performance are subject to the availability of information in the public domain